Document Detail

Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin.
MedLine Citation:
PMID:  24522239     Owner:  NLM     Status:  Publisher    
Antithrombin (AT) is a heparin-binding serpin in plasma which regulates the proteolytic activity of procoagulant proteases of the clotting cascade. In addition to being an anticoagulant, AT also exhibits antiinflammatory activities when it binds to cell surface heparan sulfate proteoglycans (HSPGs) on the endothelium via its basic residues of D-helix to elicit intracellular signalling responses. By contrast to AT, α1-proteinase inhibitor (α1-PI) is a non-heparin-binding serpin that exhibits very slow reactivity with coagulation proteases and possesses no HSPG-dependent antiinflammatory properties. To determine whether the antiinflammatory signaling specificity of AT can be transferred to α1-PI, we replaced the D-helix of human α1-PI with the corresponding sequence of human AT and expressed the chimeric serpin α1-PI/D-helix) in a bacterial expression system. High molecular weight heparin bound to α1-PI/D-helix and accelerated the inhibition of thrombin by the serpin mutant by a template mechanism reminiscent of the cofactor effect of heparin on inhibition of thrombin by AT. Like AT, α1-PI/D-helix exhibited antiinflammatory properties in both cellular and animal models. Thus, α1-PI/D-helix inhibited the barrier-disruptive effect of proinflammatory cytokines and inhibited the activation of nuclear factor-κB transcription factor in lipopolysaccharide-stimulated endothelial cells by a concentration-dependent manner. Furthermore, the chimeric serpin reduced lipopolysaccharide-mediated lethality, elicited a vascular protective effect and inhibited infiltration of activated leukocytes to the peritoneal cavity of mice in an HMGB1-mediated inflammatory model. These results suggest that grafting the D-helix of AT to α1-PI confers antiinflammatory properties on the serpin and that the chimeric serpin may have therapeutic utility for treating inflammatory disorders.
L Yang; P Dinarvand; S H Qureshi; A R Rezaie
Related Documents :
23732289 - Comparison of dynamics of wildtype and v94m human udp-galactose 4-epimerase-a computati...
24218589 - Foretinib is a potent inhibitor of oncogenic ros1 fusion proteins.
24535459 - Atpase activity and atp-dependent conformational change in the co-chaperone hop.
23834729 - Molecular determinants for subcellular trafficking of the malarial sheddase pfsub2.
23618709 - Discovery of 3-phenyl-1h-5-pyrazolylamine derivatives containing a urea pharmacophore a...
19071099 - Simultaneous binding of coenzyme and two ligand molecules into the active site of funga...
24443529 - Differential activation of staphylococcus aureus heme detoxification machinery by heme ...
10466729 - Binding of phytochrome b to its nuclear signalling partner pif3 is reversibly induced b...
11531339 - The analysis of the human high affinity ige receptor fc epsilon ri alpha from multiple ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-2-13
Journal Detail:
Title:  Thrombosis and haemostasis     Volume:  112     ISSN:  0340-6245     ISO Abbreviation:  Thromb. Haemost.     Publication Date:  2014 Feb 
Date Detail:
Created Date:  2014-2-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7608063     Medline TA:  Thromb Haemost     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A universal transition in the robustness of evolving open systems.
Next Document:  Pseudoaneurysm Formation and Repair After Mohs Micrographic Surgery: A Report of 3 Cases.